跳至主要内容
临床试验/ISRCTN70535562
ISRCTN70535562已完成不适用

Moxonidine for the treatment of fibromyalgia: a prospective double-blind, randomised, single-centre, placebo-controlled, parallel group study

Foundation for Fibromyalgia and Chronic Fatigue Syndrome (Spain)0 个研究点目标入组 60 人开始时间: 2005年11月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Ages eligible for study: 30 - 60 years
  • 2. Genders eligible for study: both
  • 3. Diagnosis of fibromyalgia defined by 1990 American College of Rheumatology (ACR) criteria

排除标准

  • 1. Psychiatric illness
  • 2. Depression
  • 3. Suicidal risk
  • 4. Substance abuse
  • 5. Pulmonary dysfunction
  • 6. Renal impairment
  • 7. Active cardiac disease
  • 8. Liver disease
  • 9. Autoimmune disease
  • 10. Cancer
  • 11. Sleep apnea
  • 12. Chronic Fatigue Syndrome
  • 13. Inflammatory bowel disease
  • 14. Contraindication of Moxonidine

研究者

发起方
Foundation for Fibromyalgia and Chronic Fatigue Syndrome (Spain)

相似试验

尚未招募
4 期
ow Dose Naltrexone in Fibromyalgia - A randomised controlled cross-over trialfibromyalgiaOther - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)
ACTRN12623000172606Metro South Hospital and Health service90
进行中(未招募)
1 期
Fibromyalgia and Naltrexone: The FINAL studyMedDRA version: 20.0Level: PTClassification code 10048439Term: FibromyalgiaSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersFibromyalgia
EUCTR2019-000702-30-DKOdense University Hospital99
已完成
不适用
Tianeptine for the treatment of fibromyalgia: a prospective double-blind, randomised, single-centre, placebo-controlled, parallel group studyFibromyalgia (FM)Musculoskeletal Diseases
ISRCTN16400909Fundacion para la Fibromialgia y el Síndrome de Fatiga Crónica (Spain)60
尚未招募
1 期
low dose naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and long coronavirus disease (long COVID) symptomsMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)Long COVIDOther - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)Infection - Other infectious diseasesNeurological - Other neurological disordersRespiratory - Other respiratory disorders / diseases
ACTRN12624001162505Griffith University56
已完成
不适用
orepinephrine-evoked pain in fibromyalgiaMusculoskeletal DiseasesSoft tissue disordersFibromyalgia
ISRCTN70707830Ignacio Chavez National Institute of Cardiology (Instituto Nacional de Cardiologia Ignacio Chavez) (Mexico)60